| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
10,082 |
9,554 |
$559K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
2,837 |
2,785 |
$200K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
2,618 |
2,587 |
$192K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
2,270 |
2,237 |
$172K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
6,667 |
6,456 |
$151K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
1,796 |
1,604 |
$145K |
| S0302 |
Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) |
11,305 |
10,744 |
$106K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
9,308 |
9,168 |
$95K |
| 99173 |
|
4,464 |
4,371 |
$73K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
775 |
758 |
$68K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
913 |
887 |
$31K |
| 90461 |
|
1,752 |
1,707 |
$30K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,348 |
1,341 |
$24K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
3,242 |
3,163 |
$23K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,674 |
1,651 |
$21K |
| 99401 |
|
1,538 |
1,535 |
$16K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
604 |
587 |
$10K |
| 0001A |
|
88 |
86 |
$4K |
| 96127 |
|
404 |
404 |
$4K |
| 0002A |
|
82 |
82 |
$4K |
| 83718 |
|
482 |
459 |
$3K |
| 87276 |
|
233 |
233 |
$3K |
| 87275 |
|
233 |
233 |
$2K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
16 |
15 |
$2K |
| 82465 |
|
492 |
467 |
$2K |
| 99050 |
|
90 |
90 |
$1K |
| ATP03 |
|
206 |
203 |
$1K |
| 99381 |
|
12 |
12 |
$1K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
19 |
19 |
$903.45 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
24 |
24 |
$680.40 |
| 92551 |
|
44 |
36 |
$342.72 |
| 99188 |
|
12 |
12 |
$252.00 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
15 |
15 |
$167.77 |
| 81000 |
|
15 |
13 |
$38.16 |
| 99000 |
|
534 |
510 |
$15.40 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
272 |
272 |
$0.00 |
| 90686 |
|
1,788 |
1,757 |
$0.00 |
| 36416 |
|
877 |
825 |
$0.00 |
| 90651 |
|
672 |
660 |
$0.00 |
| 90680 |
|
364 |
355 |
$0.00 |
| 90723 |
|
404 |
391 |
$0.00 |
| 90647 |
|
852 |
837 |
$0.00 |
| 90620 |
|
345 |
334 |
$0.00 |
| 90670 |
|
849 |
834 |
$0.00 |
| 90734 |
|
467 |
452 |
$0.00 |
| 80061 |
Lipid panel |
208 |
205 |
$0.00 |
| 90685 |
|
1,334 |
1,287 |
$0.00 |
| 90633 |
|
259 |
253 |
$0.00 |
| 91300 |
|
255 |
203 |
$0.00 |
| 90700 |
|
12 |
12 |
$0.00 |